APA (7th ed.) Citation

Lefebvre, B., Pepin, J., Baguet, J., Bessard, J., Bessard, G., Levy, P., & Stanke-Labesque, F. (2007). PO19-546 5-LIPOXYGENASE PATHWAY: ONE OF THE MEDIATORS OF EARLY ATHEROSCLEROSIS IN OBSTRUCTIVE SLEEP APNEA SYNDROME? Atherosclerosis (Supplements), 8(1), 151. https://doi.org/10.1016/S1567-5688(07)71556-8

Chicago Style (17th ed.) Citation

Lefebvre, B., J.L Pepin, J.P Baguet, J. Bessard, G. Bessard, P. Levy, and F. Stanke-Labesque. "PO19-546 5-LIPOXYGENASE PATHWAY: ONE OF THE MEDIATORS OF EARLY ATHEROSCLEROSIS IN OBSTRUCTIVE SLEEP APNEA SYNDROME?" Atherosclerosis (Supplements) 8, no. 1 (2007): 151. https://doi.org/10.1016/S1567-5688(07)71556-8.

MLA (9th ed.) Citation

Lefebvre, B., et al. "PO19-546 5-LIPOXYGENASE PATHWAY: ONE OF THE MEDIATORS OF EARLY ATHEROSCLEROSIS IN OBSTRUCTIVE SLEEP APNEA SYNDROME?" Atherosclerosis (Supplements), vol. 8, no. 1, 2007, p. 151, https://doi.org/10.1016/S1567-5688(07)71556-8.